Specjalistyczny Gabinet Dermatologiczno- Kosmetyczny
- Address
- lock Available on a paid plan
Specjalistyczny Gabinet Dermatologiczno-Kosmetyczny - Pediatric Dermatology Research
This specialized dermatological and cosmetic center in Poland is actively engaged in advanced clinical research focusing on chronic inflammatory skin conditions in pediatric populations. The center demonstrates particular expertise in evaluating novel therapeutic approaches for complex dermatological disorders requiring specialized care and long-term management strategies.
- Pharmacokinetic studies of innovative immunomodulatory agents in children and adolescents
- Treatment efficacy assessment for moderate to severe plaque psoriasis in pediatric patients aged 4-18 years
- Long-term safety evaluation of systemic dermatological therapies in young patients
The center's research portfolio includes participation in multi-phase international trials investigating deucravacitinib, a selective TYK2 inhibitor, representing cutting-edge approaches to managing plaque psoriasis in pediatric cohorts. Their involvement in comprehensive Phase 3 studies demonstrates capability in conducting complex pharmacokinetic analyses, placebo-controlled efficacy evaluations, and extended safety monitoring protocols essential for establishing treatment guidelines in vulnerable pediatric populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczny Gabinet Dermatologiczno- Kosmetyczny
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Recruiting | May 2021 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Jnj-77242113 | 2 | Unknown | 2023-12-05 | 2023-12-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.